Quantitative Visual Tests in Primary Open-angle Glaucoma Patients According to Three Different Lights with Different Color-rendering Index

Overview

Journal BMC Ophthalmol

Publisher Biomed Central

Specialty Ophthalmology

Date 2021 May 29

PMID 34049514

Authors

Sang Woo Kim

YoungWook Go

Sang-Ook Kang

Chang Kyu Lee

Affiliations

Soon will be listed here.

Abstract

Purpose: To compare quantitative visual tests, such as visual acuity, contrast sensitivity, and color vision tests in patients with primary open-angle glaucoma (POAG) patients according to three different light systems with different color-rendering index (CRI).

Methods: This was a cross-sectional study of 36 eyes in 36 patients with POAG. Three different light systems consisting of a 3-band fluorescent lamp (CRI 80), a white LED (CRI 75), and a quantum dot LED (CRI > 95) were used. All lights had the same illuminance of 230 lx to exclude illuminance effects. The visual testing included best-corrected visual acuity (BCVA) using an ETDRS chart, a CSV-1000E contrast test, and a color test performed by the Farnsworth Munsell 100-hue test.

Results: There was no significant difference in BCVA (p = 0.86). There were no significant differences in the detail contrast tests according to the three light systems (p = 0.95, p = 0.94, p = 0.94, respectively, p = 0.64). There was significant difference between the three light systems in color test (p = 0.042). The color test scores with a quantum dot LED were significantly lower than those of the white LED and 3-band fluorescent lamp (p = 0.03 and 0.047, respectively).

Conclusions: POAG patients did not show significant differences in visual acuity scores and contrast test scores, expressed as black and white symbols, according to the different light systems. However, POAG patients tested under a quantum dot LED (CRI > 95) could distinguish color differences better than in the other light systems.

References

Gunduz K, Arden G, Perry S, WEINSTEIN G, Hitchings R . Color vision defects in ocular hypertension and glaucoma. Quantification with a computer-driven color television system. Arch Ophthalmol. 1988; 106(7):929-35. DOI: 10.1001/archopht.1988.01060140075028. View

Yoon H, Oh J, Lee S, Park J, Do Y . Circadian-tunable Perovskite Quantum Dot-based Down-Converted Multi-Package White LED with a Color Fidelity Index over 90. Sci Rep. 2017; 7(1):2808. PMC: 5459832. DOI: 10.1038/s41598-017-03063-7. View

Park C, Kim D, Lee C . Near and Distance Stereoacuity in Patients With Primary Open-angle Glaucoma. J Glaucoma. 2018; 27(6):537-542. DOI: 10.1097/IJG.0000000000000963. View

Sheedy J, Bailey I, Raasch T . Visual acuity and chart luminance. Am J Optom Physiol Opt. 1984; 61(9):595-600. DOI: 10.1097/00006324-198409000-00010. View

Alqudah A, Mansberger S, Gardiner S, Demirel S . Vision-related Quality of Life in Glaucoma Suspect or Early Glaucoma Patients. J Glaucoma. 2016; 25(8):629-33. PMC: 4975427. DOI: 10.1097/IJG.0000000000000445. View

Haymes S, LeBlanc R, Nicolela M, Chiasson L, Chauhan B . Risk of falls and motor vehicle collisions in glaucoma. Invest Ophthalmol Vis Sci. 2007; 48(3):1149-55. DOI: 10.1167/iovs.06-0886. View

Niwa Y, Muraki S, Naito F, Minamikawa T, Ohji M . Evaluation of acquired color vision deficiency in glaucoma using the Rabin cone contrast test. Invest Ophthalmol Vis Sci. 2014; 55(10):6686-90. DOI: 10.1167/iovs.14-14079. View

Jampel H, Schwartz A, Pollack I, Abrams D, Weiss H, Miller R . Glaucoma patients' assessment of their visual function and quality of life. J Glaucoma. 2002; 11(2):154-63. DOI: 10.1097/00061198-200204000-00012. View

Marando C, Seibold L, SooHoo J, Pantcheva M, Ramulu P, Kahook M . The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy. Ophthalmology. 2015; 122(12):2577-8. DOI: 10.1016/j.ophtha.2015.04.039. View

10.

Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-90. DOI: 10.1016/j.ophtha.2014.05.013. View

11.

Freeman E, Egleston B, West S, Bandeen-Roche K, Rubin G . Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci. 2005; 46(11):4040-5. DOI: 10.1167/iovs.05-0687. View

12.

Chia E, Wang J, Rochtchina E, Smith W, Cumming R, Mitchell P . Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 2003; 45(1):71-6. DOI: 10.1167/iovs.03-0661. View

13.

Behar-Cohen F, Martinsons C, Vienot F, Zissis G, Barlier-Salsi A, Cesarini J . Light-emitting diodes (LED) for domestic lighting: any risks for the eye?. Prog Retin Eye Res. 2011; 30(4):239-57. DOI: 10.1016/j.preteyeres.2011.04.002. View

14.

Liu S, Sun P, Liu Y, Zhou T, Li S, Xie R . Warm White Light with a High Color-Rendering Index from a Single GdAlGaO:Ce Transparent Ceramic for High-Power LEDs and LDs. ACS Appl Mater Interfaces. 2018; 11(2):2130-2139. DOI: 10.1021/acsami.8b18103. View

15.

Del Olmo-Aguado S, Nunez-Alvarez C, Osborne N . Red light of the visual spectrum attenuates cell death in culture and retinal ganglion cell death in situ. Acta Ophthalmol. 2016; 94(6):e481-91. DOI: 10.1111/aos.12996. View

16.

Flammer J, Drance S . Correlation between color vision scores and quantitative perimetry in suspected glaucoma. Arch Ophthalmol. 1984; 102(1):38-9. DOI: 10.1001/archopht.1984.01040030022026. View

17.

Osborne N, Nunez-Alvarez C, Del Olmo-Aguado S . The effect of visual blue light on mitochondrial function associated with retinal ganglions cells. Exp Eye Res. 2014; 128:8-14. DOI: 10.1016/j.exer.2014.08.012. View

18.

Drance S, LAKOWSKI R, Schulzer M, Douglas G . Acquired color vision changes in glaucoma. Use of 100-hue test and Pickford anomaloscope as predictors of glaucomatous field change. Arch Ophthalmol. 1981; 99(5):829-31. DOI: 10.1001/archopht.1981.03930010829007. View

19.

Tu C, Hoo J, Bohringer K, Lin L, Cao G . Red-emitting silicon quantum dot phosphors in warm white LEDs with excellent color rendering. Opt Express. 2014; 22(5):A276-81. View

20.

Pomerance G, Evans D . Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy. Invest Ophthalmol Vis Sci. 1994; 35(9):3357-61. View